INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS)

$0.085 0.008 (10.3896%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 83

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) News Sources

Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight

27-10-2025

yahoo.com

external link

Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome

31-03-2026

yahoo.com

external link

INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) Sentiment Trend

0 25 50 75 100 90 77 27-10-2025 31-03-2026 #1 #2 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) FAQs

toggle

What is the current price of INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS)?

The current price of INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) is $0.085.


toggle

INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) absolute price change since previous trading day?

The absolute price change of INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) since the previous trading day is $0.008.


toggle

INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) percentage price change since previous trading day?

The percentage price change of INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) since the previous trading day is 10.3896%.


toggle

What is the most recent average sentiment score for INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS)?

The most recent average sentiment score for INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) is 83 out of 100.


toggle

What is the most recent average sentiment for INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS)?

The most recent sentiment for INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS) is .


SEC-8K** Filing Available For INHIBITOR THERAPEUTICS INC (INTI:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

INTS (Intensity Therapeutics Inc)
INBP (Integrated Biopharma Inc)
OTLC (Oncotelic Therapeutics Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.